Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Taiwan with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Not applicable Country / region: Taiwan Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20072
20081
20091
20114
20132
20141
20151
20161
20174
20185
20191
20204
20212
20226
20236
20244
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Unknown status13
Not yet recruiting5
Recruiting3
Active, not recruiting2
Enrolling by invitation2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital7
Chang Gung Memorial Hospital4
Taipei Medical University4
Taipei Veterans General Hospital, Taiwan3
Chang Gung University of Science and Technology2
Chimei Medical Center2
Chung Shan Medical University2
Fooyin University2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
National Taipei University of Nursing and Health Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 255
Diabetes Mellitus11
Insulin Resistance5
Hyperglycemia3
Cardiovascular Diseases2
Coronary Artery Disease2
Hyperlipidemias2
Hypertension2
Obesity2
Sleep Initiation and Maintenance Disorders2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.